The Costs of Adverse Drug Events in Hospitalized Patients
Authors:
- David W. BatesDBDavid W. Bates
- Nathan SpellNSNathan Spell
- David J. CullenDCDavid J. Cullen
- Elisabeth BurdickEBElisabeth Burdick
- Nan LairdNLNan Laird
- Laura A. PetersenLPLaura A. Petersen
- Stephen D. SmallSSStephen D. Small
- Bobbie J. SweitzerBSBobbie J. Sweitzer
- Lucian L. LeapeLLLucian L. Leape
- 22 January 1997
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 277 (4) , 307-311
Abstract
Research from JAMA — The Costs of Adverse Drug Events in Hospitalized PatientsKeywords
This publication has 6 references indexed in Scilit:
- Drug-related morbidity and mortality. A cost-of-illness modelArchives of internal medicine (1960), 1995
- Drug-Related Hospital AdmissionsAnnals of Pharmacotherapy, 1993
- Incidence and preventability of adverse drug events in hospitalized adultsJournal of General Internal Medicine, 1993
- Inside the Black Box of Administrative CostsHealth Affairs, 1992
- Cost Effectiveness of Bone Marrow Transplantation in Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1989
- The Distinction Between Cost and ChargesAnnals of Internal Medicine, 1982